M Higashiyama

Summary

Country: Japan

Publications

  1. ncbi request reprint Thymidylate synthase and dihydropyrimidine dehydrogenase activities in non-small cell lung cancer tissues: relationship with in vitro sensitivity to 5-fluorouracil
    M Higashiyama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1 3 3 Nakamichi, Higashinariku, Osaka 537 8511, Japan
    Lung Cancer 34:407-16. 2001
  2. ncbi request reprint Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response
    M Higashiyama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537 8511, Japan
    Oncol Rep 8:279-83. 2001
  3. pmc MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation
    M Higashiyama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases formerly, Center for Adult Diseases, Osaka, Higashinariku, Japan
    Br J Cancer 75:1302-8. 1997
  4. ncbi request reprint Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning
    K Kodama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1 3 3, Nakamichi, Higashinari ku, Osaka 537 8511, Japan
    Lung Cancer 33:17-25. 2001
  5. pmc An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis
    M Higashiyama
    Department of Thoracic Surgery, Center for Adult Diseases, Osaka, Japan
    Br J Cancer 65:300-2. 1992
  6. ncbi request reprint Transmediastinal approach to exploring the lung contralateral to the thoracotomy site
    K Kodama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan
    Jpn J Thorac Cardiovasc Surg 49:267-72. 2001
  7. ncbi request reprint Successful removal of a primitive neuroectodermal tumor in the lung with gross extension into the left atrium
    H Yokouchi
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan
    Thorac Cardiovasc Surg 47:257-9. 1999
  8. ncbi request reprint Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis
    M Higashiyama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Higashinariku, Japan
    Int J Cancer 74:205-11. 1997
  9. pmc p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung
    C I Huang
    Department of Thoracic Surgery, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Kitaku, Osaka, Japan
    Br J Cancer 82:374-80. 2000
  10. ncbi request reprint [Surgical treatment for the second double lung cancers following chemotherapy for small cell lung cancer]
    T Momozane
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
    Kyobu Geka 62:117-21. 2009

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Thymidylate synthase and dihydropyrimidine dehydrogenase activities in non-small cell lung cancer tissues: relationship with in vitro sensitivity to 5-fluorouracil
    M Higashiyama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1 3 3 Nakamichi, Higashinariku, Osaka 537 8511, Japan
    Lung Cancer 34:407-16. 2001
    ..Based on these results, further study is needed to evaluate the clinical significance of these enzymes in 5-FU-based chemotherapy for patients with NSCLC...
  2. ncbi request reprint Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response
    M Higashiyama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537 8511, Japan
    Oncol Rep 8:279-83. 2001
    ....
  3. pmc MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation
    M Higashiyama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases formerly, Center for Adult Diseases, Osaka, Higashinariku, Japan
    Br J Cancer 75:1302-8. 1997
    ..Further study is needed to determine how MDM2 protein expression results in a better prognosis...
  4. ncbi request reprint Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning
    K Kodama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1 3 3, Nakamichi, Higashinari ku, Osaka 537 8511, Japan
    Lung Cancer 33:17-25. 2001
    ..This study was undertaken to investigate the value of the ground-glass opacity (GGO) area found on high-resolution computed tomography (HRCT) scanning as a preoperative prognostic indicator...
  5. pmc An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis
    M Higashiyama
    Department of Thoracic Surgery, Center for Adult Diseases, Osaka, Japan
    Br J Cancer 65:300-2. 1992
    ..Thus, AAT expression status in tumour cells of lung adenocarcinoma may be a biological marker of prognostic significance in regard to tumour growth...
  6. ncbi request reprint Transmediastinal approach to exploring the lung contralateral to the thoracotomy site
    K Kodama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan
    Jpn J Thorac Cardiovasc Surg 49:267-72. 2001
    ..CONCLUSION: This novel approach is useful, offering the advantages of reduced invasiveness and pain, shorter surgical duration, and favorable cosmetic results for patients with a tumor close to the mediastinum in the contralateral lung...
  7. ncbi request reprint Successful removal of a primitive neuroectodermal tumor in the lung with gross extension into the left atrium
    H Yokouchi
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan
    Thorac Cardiovasc Surg 47:257-9. 1999
    ..The residual tumor was completely removed through a combined left atrial resection and right middle and lower lobectomy, using a percutaneous cardiopulmonary support system...
  8. ncbi request reprint Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis
    M Higashiyama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Higashinariku, Japan
    Int J Cancer 74:205-11. 1997
    ....
  9. pmc p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung
    C I Huang
    Department of Thoracic Surgery, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Kitaku, Osaka, Japan
    Br J Cancer 82:374-80. 2000
    ....
  10. ncbi request reprint [Surgical treatment for the second double lung cancers following chemotherapy for small cell lung cancer]
    T Momozane
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
    Kyobu Geka 62:117-21. 2009
    ..Careful follow-up especially focusing on 2nd primary lung cancer development is necessary for patients after successful treatment for small cell lung cancer...
  11. ncbi request reprint [Extrapleural pneumonectomy for relapsed solitary fibrous tumors of the pleura with pleural dissemination]
    N Miyoshi
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
    Kyobu Geka 60:800-5. 2007
    ..She died of the recurrence 15 months after the re-resection and 34 months after the prior thoracotomy...
  12. ncbi request reprint [Complete resection of Pancoast tumor following induction chemoradiotherapy improves survival]
    Ken Kodama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan
    Kyobu Geka 63:9-15. 2010
    ....
  13. ncbi request reprint Alpha-1-antichymotrypsin expression in lung adenocarcinoma and its possible association with tumor progression
    M Higashiyama
    Department of Thoracic Surgery, Center for Adult Diseases, Osaka, Japan
    Cancer 76:1368-76. 1995
    ..The authors examined ACT expression in lung adenocarcinoma to determine its clinicopathologic and prognostic significance...
  14. ncbi request reprint Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton
    M Matsumoto
    Department of Immunology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan
    Int Immunopharmacol 1:1559-69. 2001
    ..BCG-CWS-mediated Toll signaling may participate in IFNgamma induction for lymphocytes through Mphi/APC IL-12/I-18 modulation...
  15. ncbi request reprint Pros and cons of chest wall reconstruction using prosthetic meshes in a two-layer fashion
    K Kodama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
    Thorac Cardiovasc Surg 50:361-3. 2002
    ..As a result, the space was closed with an omentum flap. As a consequence, we recommend one-stage omentopexy to prevent the space problem between the two meshes...
  16. ncbi request reprint [Survey of surgical treatment of malignant pleural mesothelioma in Japan]
    M Higashiyama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan
    Kyobu Geka 60:19-24. 2007
    ..Thus, the development of multimodality therapy including surgical treatment for this disease may be required to improve surgical results of MPM patients...